AHAlejandro Herron-Bedoya

Alejandro Herron-Bedoya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alejandro Herron-Bedoya has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular and systemic modifiers of alpha-synuclein proteostasis

    by Suzanne Couzijn, Anna P. Ainslie, Alejandro Herron-Bedoya, Ellen A. A. Nollen

    Ageing is a primary risk factor for neurodegenerative disorders, including Parkinson's disease (PD). As individuals age, their cells become less efficient in maintaining protein homeostasis, leading to an increased likelihood of protein misfolding and aggregation. A hallmark of PD and other synucleinopathies is the accumulation of alpha-synuclein protein aggregates in affected neurons, a process that is exacerbated by ageing. While cellular mechanisms that regulate protein aggregation have been a primary focus of research, recent studies suggest that other, systemic age-related mechanisms may contribute to alpha-synuclein toxicity. Understanding these alternative pathways is crucial for the development of effective therapeutic strategies to combat neurodegenerative diseases, such as PD. In this review, we synthesize current insights into the biological mechanisms underlying alpha-synuclein toxicity at the organismal level. We highlight key open questions and discuss how these findings may inform the development of targeted interventions to prevent or delay age-related synucleinopathies. This article is part of the Theo Murphy meeting issue ‘ProteostaSys: a systems view of proteostasis’.

  • A Semi-physical Model for Glucose Kinetics and Dynamics in Subcutaneous Adipose Tissue

    by Alejandro Herron-Bedoya, Manuela Walteros-Leon

    In this work, a Phenomenological-Based Semi-physical Model (PBSM) for glucose dynamics and kinetics in adipose tissue is used to simulate glucose concentration in the interstitial fluid (ISF) of subcutaneous adipose tissue. This PBSM was built from analogies between physiology and process engineering, and allows adjusting parameters such as subcutaneous adipose tissue thickness, apparent glucose diffusivity, one-point postprandial blood glucose concentration and its corresponding ISF glucose concentration, maximum glucose uptake rate by adipocytes and glucose concentration at which half the maximum glucose uptake rate is achieved. Also, a comparison and analysis between ISF glucose simulated using two empirically-based models is presented. Previous results achieved using the PBSM model show that physiological delay time between glucose concentration in blood and ISF is in the order of 8-9 minutes, and the current results suggest that interstitial glucose dynamic concentration simulated using the PBSM behaves in accordance with both empirically-based models.